• 1
    Schifferli JA, Taylor RP. Physiological and pathological aspects of circulating immune complexes. Kidney Int 1989; 35: 9931003.
  • 2
    Mannik M. Pathophysiology of circulating immune complexes. Arthritis Rheumat 1982; 25: 7837.
  • 3
    Kasai S, Akaike T, Kunimoto T, Nitta K. Superoxide anion production from mouse peritoneal macrophages stimulated with surface-bound IgG and immune complexes: adsorption characteristics of IgG in relationship to biological activity. Eur J Immunol 1982; 12: 10547.
  • 4
    Bonney RJ, Naruns P, Davies P, Humes JL. Antigen–antibody complexes stimulate the synthesis and release of prostaglandins by mouse peritoneal macrophages. Prostaglandins 1979; 18: 60516.
  • 5
    Rouzer CA, Scott WA, Hamill AL, Liu FT, Katz DH, Cohn ZA. Secretion of leukotriene C and other arachidonic acid metabolites by macrophages challenged with immunoglobulin E immune complexes. J Exp Med 1982; 156: 107786.
  • 6
    Polat GL, Laufer J, Fabian I, Passwell JH. Cross-linking of monocyte plasma membrane Fc alpha, Fc gamma or mannose receptors induces TNF production. Immunology 1993; 80: 28792.
  • 7
    Berger S, Balló H, Stutte HJ. Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes. a network of pro- and anti-inflammatory cytokines dependent on the antigen : antibody ratio. Eur J Immunol 1996; 26: 1297301.
  • 8
    Nitta T, Suzuki T. Biochemical signals transmitted by Fc-gamma receptors. triggering mechanisms of the increased synthesis of adenosine-3′, 5′-cyclic monophosphate mediated by Fc-gamma2a- and Fc-gamma2b-receptors of a murine macrophage-like cell line (P388D1). J Immunol 1982; 129: 270814.
  • 9
    Ravetch JV, Kinet JP. Fc receptors. Annu Rev Immunol 1991; 9: 45792.
  • 10
    Clynes R, Ravetch JV. Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity 1995; 3: 216.
  • 11
    Daëron M. Fc receptor biology. Annu Rev Immunol 1997; 15: 20334.
  • 12
    Virgin HW, Wittenberg GF, Unanue ER. Immune complex effects on murine macrophages. I. Immune complexes suppress interferon-γ induction of Ia expression. J Immunol 1985; 135: 373543.
  • 13
    Revel M, Chebath J. Interferon-activated genes. Trends Biochem Sci 1986; 11: 16670.
  • 14
    Hanaumi K, Gray P, Suzuki T. Fcγ receptor-mediated supression of γ-interferon-induced Ia antigen expression on a murine macrophage-like cell line (P338D1). J Immunol 1984; 133: 28526.
  • 15
    Farraf MA, Schreiber RD. The molecular cell biology of interferon-γ and its receptor. Annu Rev Immunol 1993; 11: 571611.
  • 16
    Rosa FM, Cochet MM, Fellous M. Interferon and major histocompatibility complex genes: a model to analyse eukaryotic gene regulation? Interferon 1986; 7: 4887.
  • 17
    Van Weyenbergh J, Lipinski P, Abadie A, Chabas D, Blank U, Liblau R, Wietzerbin J. Antagonistic action of IFN-β and IFN-γ on high affinity Fcγ receptor expression in healthy controls and multiple sclerosis patients. J Immunol 1998; 161: 156874.
  • 18
    Barrionuevo P, Beigier-Bompadre M, De La Barrera S et al. Immune complexes (IC) dowregulate the basal and interferon-γ-induced expression of MHC class II on human monocytes. Clin Exp Immunol 2001; 125 (2):2517.
  • 19
    Isturiz MA, Fink S, Bracco MME. Reversal of immune complex inhibition of antibody dependent cell mediated cytotoxicity by normal human serum. Clin Exp Immunol 1982; 48: 68592.
  • 20
    Geffner J, Giordano M, Serebrinsky G, Palermo M, Isturiz MA. Inhibition of lymphocyte and monocyte ADCC by immune complexes: effect of normal human serum. Immunol Lett 1987; 15: 2559.
  • 21
    De la Barrera S, Sasiain MC, Geffner J, Isturiz MA, Segal-Eiras A, Bracco MME. Inhibition of antibody-dependent cell-mediated cytotoxicity by serum from lepromatous leprosy patients. Int J Lepr Other Mycobact Dis 1985; 53: 21824.
  • 22
    Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968; 97: 7789.
  • 23
    Tosi MF, Zakem H. Surface expression of Fc gamma receptor III (CD16) on chemoattractant-stimulated neutrophils is determined by both surface shedding and translocation from intracellular storage compartments. J Clin Invest 1992; 90: 46270.
  • 24
    Fleisher TA, Dorman SE, Anderson JA, Vail M, Brown MR, Holland SM. Detection of intracellular phosphorylated STAT-1 by flow cytometry. Clin Immunol 1999; 90: 42530.
  • 25
    Lanari C, Molinolo AA, Pasqualini CD. Inhibitory effect of medroxyprogesterone acetate on foreign body tumorigenesis in mice. J Natl Cancer Inst 1986; 77: 15764.
  • 26
    Miller GW, Nussenzweig V. A new complement function: solubilization of antigen–antibody aggregates. Proc Natl Acad Sci USA 1975; 72: 41822.
  • 27
    Czop J, Nussenzweig V. Studies on the mechanism of solubilization of immune precipitates by serum. J Exp Med 1976; 143: 61530.
  • 28
    Takahashi M, Tack BF, Nussenzweig V. Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes. J Exp Med 1977; 145: 86100.
  • 29
    Hong K, Takata Y, Sayama K et al. Inhibition of immune precipitation by complement. J Immunol 1984; 133: 146470.
  • 30
    Koppelman B, Neefjes JJ, De Vries JE, De Waal Malefyt R. Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting and recycling. Immunity 1997; 7: 86171.
  • 31
    Feldman GM, Chuang EJ, Finbloom DS. IgG immune complexes inhibit IFN-γ -induced transcription of the Fcγ RI gene in human monocytes by preventing the tyrosine phosphorylation of the p91 (Stat1) transcription factor. J Immunol 1995; 154: 31825.
  • 32
    Takahashi M, Czop J, Ferreira A, Nussenzweig V. Mechanism of solubilization of immune aggregates by complement. Implication for immunopathology. Transplant Rev 1976; 32: 12139.
  • 33
    Takahashi M, Takahashi S, Hirose S. Solubilization of antigen–antibody complexes: a new function of complement as a regulator of immune reactions. Prog Allergy 1980; 27: 13466.
  • 34
    Schifferli JA, Bartolotti SR, Peters DK. Inhibition of precipitation by complement. Clin Exp Immunol 1980; 42: 38794.
  • 35
    Schifferli JA, Woo P, Peters DK. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways. Clin Exp Immunol 1982; 47 (3):55562.
  • 36
    Schifferli JA, Peters DK. Complement-mediated inhibition of immune precipitation. II. Analysis by sucrose density gradient ultracentrifugation. Clin Exp Immunol 1982; 47: 5639.